Company
Glympse Bio
- Status
- Acquiredas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Glympse Bio (acquired by SunBird Bio) has developed technology to diagnose diseases like NASH and multiple forms of cancer at their earliest stages, when they are far more easily treatable.
About the company
- Status notes
- acquired by SunBird Bio
Loading relationship preview